AstraZeneca's Covid-19 Antibody Therapy Effective In Preventing Symptoms Among High-Risk Groups, Trial FindsForbes • 08/20/21
AstraZeneca says antibody drug phase III trial shows significant reduction in symptomatic Covid-19Proactive Investors • 08/20/21
Britain Study Shows Restricted Use Of AstraZeneca COVID-19 Shot Associated With No Clot Cases: ReutersBenzinga • 08/12/21
Thursday Afternoon Analyst Upgrades and Downgrades: Chipotle, eBay, Nvidia, Qualcomm, Tesla and More24/7 Wall Street • 08/12/21
Do Options Traders Know Something About AstraZeneca (AZN) Stock We Don't?Zacks Investment Research • 08/12/21
Blood clots associated with AstraZeneca vaccine are ‘rare but devastating,' study saysCNBC • 08/12/21
Are AstraZeneca shares worth buying? Read what this big hitting City broker has to say before making your callProactive Investors • 08/12/21
AstraZeneca, Daiichi Sankyo's Enhertu Shows Improved PFS Over Roche's Kadcyla In Breast CancerBenzinga • 08/09/21
AstraZeneca offers sector-leading growth at reasonable price, says Morgan StanleyProactive Investors • 08/09/21
LogicBio Therapeutics (LOGC) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/09/21
LogicBio Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company MilestonesPRNewsWire • 08/09/21
AstraZeneca PLC boss urges rival at GlaxoSmithKline to stick to her gunsProactive Investors • 08/06/21
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis PipelineBusiness Wire • 08/05/21